Skip to main content

Month: February 2021

Incap Oyj: Incap-konsernin tilinpäätöstiedote tammi–joulukuulta 2020 (tilintarkastamaton): Liikevaihdon kasvu ja hyvä kannattavuus jatkuivat

Incap Oyj                                                Incap-konsernin tilinpäätöstiedote tammi–joulukuulta 2020 (tilintarkastamaton): Liikevaihdon kasvu ja hyvä kannattavuus jatkuivatTämä tiedote on tiivistelmä Incapin tilinpäätöstiedotteesta tammi–joulukuulta 2020. Koko raportti löytyy tämän pörssitiedotteen liitteenä pdf-tiedostona sekä yhtiön verkkosivuilla osoitteessa www.incapcorp.com.Loka–joulukuun 2020 kohokohdatVuoden 2020 neljännen vuosineljänneksen liikevaihto oli 31,5 milj. euroa (10–12/2019:16,3 milj. euroa). Kasvu oli 94 %.Tammikuussa 2020 hankitun AWS Electronics Groupin liikevaihto pois lukien liikevaihto kasvoi orgaanisesti 45 %.Oikaistu liikevoitto (EBIT) oli 5,6 milj. euroa (2,7 milj. euroa) eli 17,7 % liikevaihdosta (16,3 %).AWS Electronics Groupin yritysoston hankintamenon kohdistamiseen (PPA) liittyvät poistot...

Continue reading

2020 Annual Results: SCOR absorbs the shock of Covid-19, recording a net income of EUR 234 million in 2020, and proposes a dividend of EUR 1.80 per share

Press ReleaseFebruary 24, 2021 – N° 42020 Annual ResultsSCOR absorbs the shock of Covid-19, recording a net income of EUR 234 million in 2020, and proposes a dividend of EUR 1.80 per share2020 was marked by the historic global shock of Covid-19, as well as by a series of natural catastrophes and large man-made losses. SCOR successfully passed this real-life stress test, once again demonstrating the resilience of its business model and its shock-absorbing capacity. The Group accomplished its mission, honoring all its commitments to its clients and contributing to the protection of the people and property affected by these losses, while delivering a good set of results.SCOR continues to actively implement its strategic plan “Quantum Leap”, focused on the twofold targets of profitability and solvency, accelerating its use of new technologies...

Continue reading

Résultats annuels 2020 : SCOR absorbe le choc de la pandémie de Covid-19, dégageant un résultat net de EUR 234 millions en 2020, et propose un dividende de EUR 1.80 par action

Communiqué de presse24 février 2021 – N° 4Résultats annuels 2020SCOR absorbe le choc de la pandémie de Covid-19, dégageant un résultat net de EUR 234 millions en 2020, et propose un dividende de EUR 1.80 par actionL’année 2020 a été marquée par le choc historique et global de la pandémie de Covid-19 mais aussi par une série de catastrophes naturelles ainsi que par des sinistres industriels et commerciaux de grande ampleur. SCOR a passé avec succès ce stress test grandeur nature, démontrant une nouvelle fois la résilience de son modèle économique et sa faculté à absorber les chocs. Le Groupe a accompli sa mission, honorant tous ses engagements envers ses clients et contribuant à la protection des personnes et des biens affectés par ces sinistres, tout en parvenant à dégager des résultats de qualité.SCOR poursuit activement...

Continue reading

Basilea successfully placed 1 million new registered shares, raising gross proceeds of CHF 45.75 million

NOT FOR RELEASE, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA, JAPAN OR ANY OTHER JURISDICTION WHERE TO DO SO WOULD BE UNLAWFULBasel, Switzerland, February 24, 2021Basilea Pharmaceutica Ltd. (“Basilea” or the “Company”) announced today that it has successfully placed 1 million new shares in a private placement to institutional shareholders by way of an accelerated bookbuilding. The net proceeds will be used for i) the clinical development of Basilea’s clinical oncology drug candidates derazantinib and lisavanbulin, ii) pre-clinical research and development activities, and iii) working capital and other general corporate purposes, including investments in or in-licensing of complementary businesses, products or assets.David Veitch, Chief Executive Officer of Basilea, said: “Through this transaction...

Continue reading

Basilea platziert erfolgreich 1 Million neue Namenaktien und erzielt dabei einen Bruttoerlös von CHF 45.75 Millionen

NOT FOR RELEASE, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA, JAPAN OR ANY OTHER JURISDICTION WHERE TO DO SO WOULD BE UNLAWFULBasel, Schweiz, 24. Februar 2021Basilea Pharmaceutica AG („Basilea“ oder die „Gesellschaft“) gab heute bekannt, dass sie erfolgreich 1 Million neue Namenaktien im Rahmen einer Privatplatzierung an institutionelle Aktionäre mittels eines Accelerated-Bookbuilding-Verfahrens platziert hat. Der Nettoerlös wird verwendet für i) die klinische Entwicklung von Basileas klinischen Onkologie-Medikamentenkandidaten Derazantinib und Lisavanbulin, ii) die präklinische Forschungs- und Entwicklungsaktivitäten und iii) das Nettoumlaufvermögen und andere allgemeine Unternehmenszwecke, einschliesslich Investitionen in oder In-Licensing von komplementären Geschäften, Produkten oder Vermögenswerten.David...

Continue reading

Sievi Capitalin vuoden 2020 selvitys hallinto- ja ohjausjärjestelmästä sekä toimielinten palkitsemisraportti julkaistu:

Sievi Capital OyjPörssitiedote 24.2.2021 klo 8.05Sievi Capitalin vuoden 2020 selvitys hallinto- ja ohjausjärjestelmästä sekä toimielinten palkitsemisraportti julkaistu Sievi Capital Oyj:n vuoden 2020 selvitys hallinto- ja ohjausjärjestelmästä sekä toimielinten palkitsemisraportti on julkaistu tämän pörssitiedotteen liitteinä sekä yhtiön verkkosivuilla www.sievicapital.fi/sijoittajat.Yhtiön vuosikertomus vuodelta 2020 julkaistaan viikolla 10. SIEVI CAPITAL OYJ Päivi Marttilatoimitusjohtaja LISÄTIETOJA:toimitusjohtaja Päivi Marttila, puh. 0400 285 358 JAKELU:Nasdaq Helsinki OyKeskeiset tiedotusvälineetwww.sievicapital.fiSievi Capital on pörssilistattu (Nasdaq Helsinki) pääomasijoitusyhtiö, joka tekee sijoituksia pieniin ja keskisuuriin suomalaisiin yrityksiin. Sievi Capital on kohdeyritysten johdon ja kanssaomistajien kumppani, joka aktiivisena...

Continue reading

Sievi Capital’s Corporate Governance Statement and Governing bodies’ Remuneration Report for 2020 published

Sievi Capital OyjStock exchange release, 24 February 2021 at 8.05 am EETSievi Capital’s Corporate Governance Statement and Governing bodies’ Remuneration Report for 2020 publishedSievi Capital Plc’s Corporate Governance Statement and Governing bodies’ Remuneration Report for 2020 have been published as attachments to this stock exchange release and are also available on the Company’s website www.sievicapital.fi/en/investors.The Annual Report for 2020 will be published during week 10.SIEVI CAPITAL PLC Päivi MarttilaCEO FURTHER INFORMATION:CEO Päivi Marttila, tel. +358 400 285 358 DISTRIBUTION:Nasdaq Helsinki LtdMajor mediawww.sievicapital.fiSievi Capital is a listed (Nasdaq Helsinki) private equity investment company that invests in small and medium-sized Finnish companies. Sievi Capital acts in close partnership with management and co-owners...

Continue reading

Atos completes the acquisition of leading cybersecurity services company Motiv

Paris, February 24, 2021 – Atos today announced that it has completed the acquisition of Motiv ICT Security, the largest independent Managed Security Services (MSS) provider in the Netherlands.This move reinforces Atos’s position as the 3rd worldwide Managed Security Services provider1 by strengthening the Group’s local capabilities and bringing its recent investment in the Managed Detection and Response (MDR) platform, AIsaac, to Dutch customers. In addition, Motiv’s sovereign Security Operations Center (SOC), independently certified at the highest levels of maturity, further expands Atos’s extensive network of global SOCs, a pivotal component of the Atos Prescriptive Security approach.This cybersecurity acquisition joins those of Paladion, digital.security, SEC Consult and more recently In Fidem that were made over the past few months...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.